Screener
Axsome Therapeutics AXSM Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's current ratio?
- Axsome Therapeutics (AXSM) reported current ratio of 1.4× in Q1 2026.
- How has Axsome Therapeutics's current ratio changed year-over-year?
- Axsome Therapeutics's current ratio decreased by 31.4% year-over-year, from 2× to 1.4×.
- What is the long-term trend for Axsome Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Axsome Therapeutics's current ratio has grown at a -27.7% compound annual growth rate (CAGR), from 7.9× to 1.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Axsome Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude